Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

J&J’s subcutaneous Rybrevant receives positive CHMP opinion for advanced lung cancer

The formulation significantly reduces administration time compared to the approved intravenous version

- PMLiVE

MHRA approves CSL’s Andembry to treat angioedema attacks in HAE patients

The rare genetic condition occurs in approximately one in every 50,000 people in the UK

Why events should be part of your 2025 growth strategy

Over eighty per cent of businesses rank in-person events as their most impactful marketing channel. In fact, 48 per cent of teams say events are more important today than pre-pandemic. When done...

EatMoreFruit

- PMLiVE

Optimising business partnerships for success and sustainability

Building trust between all stakeholders to enhance business relationships and improve outcomes

- PMLiVE

Amgen’s Blincyto granted EC approval for new acute lymphoblastic leukaemia indication

B-ALL is the most common form of the blood cancer, accounting for approximately 75% of adult cases

- PMLiVE

NICE approves Vertex’s Casgevy one-time gene therapy for sickle cell disease

About 15,000 people in England are living with the inherited blood disorder

- PMLiVE

ICR researchers uncover new method for predicting bowel cancer risk in IBD patients

Approximately 500,000 people in the UK are affected by Crohn’s disease or ulcerative colitis

- PMLiVE

Keto, CAR-T and creativity: insights from ASH 2024

With a menu featuring everything from cutting-edge science to DEI and diet, ASH 2024 certainly offered congress attendees food for thought

- PMLiVE

See What’s Shaping Pharma Education in 2025: Join Our Free Webinar

From AI to VR, and everything in between—explore the cutting-edge tools revolutionizing medical training. Learn why these advancements are crucial for maintaining standards and excelling in the rapidly evolving landscape...

Impetus Digital

Optimizing Team Meetings in Remote Work – Building Company Culture Virtually

Rethink your approach to team meetings in a remote setting. Discover strategies for balancing synchronous and asynchronous communications to maximize decision-making and minimize meeting fatigue. Explore our tips for structuring...

Impetus Digital

- PMLiVE

UK access pathway launched to get new medicines to patients in ‘shortest time possible’

The ILAP offers drug developers a single platform to collaborate with the MHRA and HTA bodies

- PMLiVE

Sanofi’s Sarclisa combination approved by MHRA for newly diagnosed multiple myeloma

An estimated 5,900 new cases of the disease are diagnosed in the UK every year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links